Does OCRELIZUMAB Cause Dysphonia? 185 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Dysphonia have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.3% of all adverse event reports for OCRELIZUMAB.
185
Reports of Dysphonia with OCRELIZUMAB
0.3%
of all OCRELIZUMAB reports
1
Deaths
48
Hospitalizations
How Dangerous Is Dysphonia From OCRELIZUMAB?
Of the 185 reports, 1 (0.5%) resulted in death, 48 (25.9%) required hospitalization, and 2 (1.1%) were considered life-threatening.
Is Dysphonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Dysphonia?
FLUTICASONE\SALMETEROL (1,729)
CABOZANTINIB S-MALATE (1,229)
ADALIMUMAB (1,216)
BUDESONIDE\FORMOTEROL (1,204)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143)
ALBUTEROL (1,114)
LENVATINIB (1,021)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943)
LENALIDOMIDE (931)
AMIKACIN (914)
Which OCRELIZUMAB Alternatives Have Lower Dysphonia Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE